Why Value-Based Health Care Is Here To Stay
Necessity Is The Mother Of Invention
COVID-19 has disrupted the operational schedules of health care and technology providers alike to unparalleled levels in 2020. But scratch the surface, and outcomes-oriented, value-based health care targets remains a priority – albeit competing a little harder for attention at present.
You may also be interested in...
Smart use of healthcare technology improves care delivery, saves time, increases productivity and can improve staff morale. At some point in the usage cycle, savings will start to be made, although when this happens – and whether it should be the prime reason for the adoption of IT-based healthcare delivery solutions – is open to debate. What is clear is that a modern approach is vital if state-provided healthcare, as we know it, is to remain sustainable in the long term. The private and public sectors both have key roles to play, says Ashley Yeo, at the second annual HETTExpo
The latest Asian Regulatory Discussions heard about Malaysia’s five-year device certificate renewal concerns, Vietnam industry’s suggestion for device fast-task approval routes, and the Philippines industry’s transition needs as the country’s new AMDD-based regulatory system gets up and running. Device news from Singapore and Thailand was also reported at the September 2021 discussion teleconference, organized by the ARQon consultancy and the Asia Regulatory Professional Association.
Swiss domestic medtech manufacturers reluctantly accept Switzerland’s new status as a third country to the EU, but the Swiss industry is anxious that new national regulations do not impose higher hurdles than the EU MDR. At present, there is a risk of that happening.